Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ONVO.NASDAQ

Organovo Holdings Inc (ONVO NASDAQ) stock market data APIs

$0.57 -0.02(-3.4%) as of July 26, 2024
Price chart is built with Anychart

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3 clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus on non-alcoholic steatohepatitis and primary biliary cholangitis. It has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California.

Organovo Holdings Inc Financial Data Overview

0.5894
0.57
-
0.5959
0.5595
0.55-2.05
8 245 K
14 372 K
109 K
-0.29
0.675
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ONVO',
Type: 'Common Stock',
Name: 'Organovo Holdings Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001M8GFD0',
ISIN: NULL,
CUSIP: NULL,
CIK: '1497253',
EmployerIdNumber: '27-1488943',
FiscalYearEnd: 'March',
IPODate: '2012-02-14',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Organovo Holdings Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 109 K
  • EBITDA -14 806 000
  • Earnings Per Share -1.62
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Organovo Holdings Inc Earnings via APIs

  • Latest Release 2024-05-31
  • EPS/Forecast -0.42

Get Organovo Holdings Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Organovo Holdings Inc latest news via APIs

Top 15 3D Printing Companies in the US

In this article, we will take a look at the top 15 3D printing companies in the US. If you want to skip our detailed analysis, you can go directly to Top 5 3D Printing Companies in the US. Recent Tre...

CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan

SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on November 8, 2023 by Organovo, Inc. (NASDAQ: ONVO), a link was incorrect. The corrected release follows: O...
  • 3D BIOPRINTING
  • FXR314
  • INC
  • INFLAMMATORY BOWEL DISEASE
  • NASDAQ:ONVO
  • ORGANOVO
  • PRODUCT / SERVICES ANNOUNCEMENT
  • ULCERATIVE COLITIS
Do you have any questions?
support@eodhistoricaldata.com